Infectious Disease Billing for Practices That Run From Organism to Outcome
Infectious disease revenue lives in consult and level-of-care selection, infusion administration time, the medical-necessity bridge between IV and oral step-down therapy, sepsis coding to specificity, and OPAT supervision. ProvidaRCM runs the full medical billing service cycle for ID practices, from eligibility verification and prior authorization through coding, claims, and denial recovery.
Infectious Disease Services We Bill
From the inpatient consult that anchors ID revenue through infusion administration, OPAT supervision, HIV and hepatitis management, and antimicrobial stewardship documentation, we bill the full range of services an ID practice delivers.
IV Antimicrobial Infusion and Administration
The highest-leverage ID revenue line. Time-based infusion codes paired with the J-code for the drug, with drug waste reported under JZ or JW. Full time-ladder detail in the section below.
Inpatient ID Consults and Management
Initial and subsequent hospital care, with the correct level selected from medical decision making and admitted patient acuity, and consult codes used only where the payer permits.
Sepsis and Critical Care
Sepsis coded to organism specificity with the present-on-admission indicator, severe sepsis with organ dysfunction, and critical care time documented for 99291 and 99292.
OPAT Supervision
Outpatient parenteral antimicrobial therapy supervision, with the supervising physician documented, the care plan on file, and home infusion services coded where the patient is managed at home.
Outpatient ID Clinic and E/M
New and established office visits, with modifier 25 when an infusion or procedure shares the encounter and distinct documentation supports both.
HIV and Hepatitis Management
Chronic HIV, asymptomatic HIV status, chronic hepatitis B and C management, antiretroviral monitoring, and viral genotyping billed with the correct diagnosis and laboratory codes.
Tuberculosis and Public-Health Reporting
Active and latent tuberculosis management, culture and sensitivity tracking, and public-health reporting documentation supported for the encounter.
Antimicrobial Stewardship Documentation
Stewardship review and de-escalation documented to support the medical-necessity bridge between IV therapy and oral step-down, with the IV-to-oral conversion captured cleanly.
Post-Discharge Follow-Up
Transitional and follow-up visits after an ID admission, with OPAT continuation, repeat culture review, and the oral step-down documented to close the episode.
Infectious Disease Code Reference
The CPT, HCPCS, and ICD-10 codes an ID practice bills most often, grouped by category. Verify every code and description against the current published versions and payer policy, and ensure each is supported by provider documentation.
| Code | Description | Billing Consideration |
|---|---|---|
| 99202 | Office visit, new patient, straightforward MDM | Low-acuity new patient ID visit. Selection is driven by medical decision making and time under the 2021 E/M revisions. |
| 99213 | Office visit, established patient, low MDM | Stable chronic infection follow-up, such as managed HIV or resolved hepatitis, when MDM is low complexity. |
| 99214 | Office visit, established patient, moderate MDM | Common ID follow-up with medication management, lab review, or a new complaint. The workhorse of the ID clinic. |
| 99215 | Office visit, established patient, high MDM | High-complexity decision making, such as treatment failure, drug resistance, or a new severe diagnosis. |
| 99221 | Initial hospital care, low MDM | Initial hospital visit for an admitted patient. Substitute for a consult for Medicare, which does not pay consult codes. |
| 99223 | Initial hospital care, high MDM | High-complexity admission, such as sepsis or a complicated infection. Used in place of 99244 to 99246 for Medicare patients. |
| 99244 | Office consultation, moderate MDM, non-Medicare | Reported only to non-Medicare payers that still cover consult codes. Medicare denies consult codes, so use 99221 to 99223 instead. |
| 99291 | Critical care, first 30 to 74 minutes | Time-based. Document cumulative minutes across the day for sepsis or other critical ID presentations. Only one E/M per date. |
| Code | Description | Billing Consideration |
|---|---|---|
| 96360 | IV hydration, first 31 to 60 minutes | Hydration, not infusion of a drug. Reported when hydration is the only service and lasts over 30 minutes. |
| 96361 | IV hydration, each additional hour | Each additional hour of hydration beyond the first. Document start and stop times. |
| 96365 | IV infusion, therapeutic, prophylactic, diagnostic, first hour | Requires infusion time greater than 1 hour. Under 1 hour, use 96372 IV push. Document the start and stop times. |
| 96366 | IV infusion, each additional hour | Each additional hour beyond the first hour of 96365. Captured only when infusion time crosses the hourly threshold. |
| 96367 | IV infusion, sequential, first hour of a different drug | A second distinct drug infused sequentially after the first. Document each drug start and stop separately. |
| 96368 | IV infusion, concurrent, first hour of a different drug | A second drug infused at the same time as the first. Concurrent infusion, distinct from sequential. |
| 96372 | IV push, therapeutic, prophylactic, or diagnostic | Infusion of 15 minutes or less, or under the 1-hour threshold for 96365. The correct downgrade when 96365 time is not met. |
| 99605 | Home infusion services, per visit, non-hydration | Home infusion services code reported per visit for non-hydration infusions. Verify current CPT description and payer policy before submission. |
| Code | Description | Billing Consideration |
|---|---|---|
| J0696 | Ceftriaxone sodium, injection, per 250 mg | Reported per unit. Units must match the documented dose given. Verify the current HCPCS description and unit before submission. |
| J0879 | Daptomycin, injection, per documented unit | High-cost agent often requiring prior authorization. Verify the current HCPCS description, unit, and dosage against the published version. |
| J0715 | Ceftazidime, injection, per 500 mg | Confirm the current HCPCS description and unit. Report units that match the dose given and supported by the medication record. |
| J0271 | Acyclovir, injection, per documented unit | Antiviral infusion agent. Confirm the current HCPCS description and unit against the published version before submission. |
| JZ / JW | Drug waste modifiers | JZ indicates no discarded amount from a single-use vial. JW reports the actual discarded amount. Confirm payer policy on modifier use. |
| Code | Description | Billing Consideration |
|---|---|---|
| 87070 | Culture, bacterial, any source, with isolation and presumptive ID | The base culture code. Reported once per specimen. Additional workup codes are reported separately where performed. |
| 87088 | Culture, anaerobic, with isolation and presumptive ID | Anaerobic culture. Reported where anaerobic isolation is performed. Verify current code status. |
| 87186 | Susceptibility study, antimicrobial, quantitative | Minimum inhibitory concentration testing. Reported once per organism per study. Supports the antimicrobial selection. |
| 87880 | Infectious agent antigen detection by immunoassay | Rapid antigen detection, such as influenza or respiratory panels. Reported per organism where performed. |
| 87797 | Nucleic acid detection, infectious agent, direct probe | Direct nucleic acid probe for a single organism. Distinct from amplification, which is reported with 87798. |
| 87506 | HIV genotyping, infectious agent detection | HIV genotype analysis for resistance. Supports antiretroviral management. Verify current code status and payer policy. |
CPT, HCPCS, and ICD-10-CM code sets are updated annually and must be verified against the current published versions and supported by provider documentation. J-codes in particular change frequently, and the unit, dosage, and description should be confirmed before every submission. Requirements may vary by payer, plan, and applicable regulations.
The Infusion Time Ladder
Infusion administration is sold by the minute, and every ID billing line lives or dies on the start and stop times in the record. The ladder below is the rule we apply to every IV antimicrobial infusion so the right code is selected and no hour is left unbilled.
| Code | Time threshold | Rule | Documentation that supports it |
|---|---|---|---|
| 96360 | 31 to 60 min | First hour of hydration only, no drug. Under 31 minutes, hydration is not separately reported. | Hydration start and stop, and that no drug was infused. |
| 96365 | Greater than 1 hr | First hour of a therapeutic IV infusion, such as an antimicrobial. If infusion time is 1 hour or less, downgrade to 96372 IV push. | Drug start and stop times, the drug given, and the J-code on the line. |
| 96366 | Each additional hr | Each additional hour beyond the first of the same drug. Captured only when the documented time crosses the next hourly threshold. | Cumulative start and stop times on the same drug line. |
| 96367 | First hr, different drug | Sequential infusion of a second distinct drug after the first. Each new drug starts a new first-hour line. | Separate start and stop times for the second drug, and that it followed the first. |
| 96368 | First hr, same time | Concurrent infusion of a second distinct drug at the same time as the first. Distinct from sequential. | Overlapping start and stop times for two distinct drugs. |
| 96372 | 15 min or less | IV push, therapeutic. Used when infusion is 15 minutes or less, or as the downgrade when 96365 time is not met. | Drug, dose, and the push time or the documented short infusion. |
Sepsis Coding and Present-on-Admission
Sepsis is the highest-stakes inpatient ID diagnosis. Coding it to specificity, capturing the present-on-admission indicator correctly, and linking the time-based critical care codes is where hospital ID revenue is won or lost. Unspecified sepsis codes leave money on the table and trigger denials when a specific organism is documented.
Infectious Disease Denial Patterns We Fix
ID denials cluster around infusion time, the medical-necessity bridge between IV and oral therapy, drug waste reporting, consult code misuse, and sepsis specificity. We prevent each pattern before submission and recover the ones already on the books.
IV antimicrobial denied for lack of oral step-down medical necessity
The payer requires documented medical necessity for IV therapy when an oral equivalent exists, and the claim denies without it.
Infusion time under-documented for 96365
96365 requires infusion time greater than 1 hour. Under the threshold, it downgrades to 96372 IV push or denies entirely.
Drug waste not reported with JZ or JW
Wasted drug from a single-use vial must be reported with the JZ or JW modifier, or the waste portion is not reimbursed.
NDC and HCPCS units mismatch
The NDC units on the claim do not match the HCPCS J-code units, so the drug line denies as a billing discrepancy.
Prior authorization missing for high-cost agents
High-cost antimicrobials such as daptomycin often require prior authorization, and the infusion denies when it is not on file.
Consult code 99244 to 99246 billed to Medicare
Medicare does not pay consult codes. A 99244 to 99246 consult billed to Medicare denies, and the encounter must be re-billed as initial hospital care.
Sepsis coded unspecified when a specific code exists
A41.9 unspecified sepsis is billed when the record identifies the organism, and the payer downcodes or denies the more specific line.
OPAT supervision unsupported
Outpatient parenteral antimicrobial therapy requires documented physician supervision, and the claim denies when the supervision is not in the record.
How We Run Your Infectious Disease Revenue Cycle
A six-step lifecycle built around eligibility and prior authorization for high-cost agents, infusion time documentation, the 96365 and 96366 ladder, drug waste reporting, and medical-necessity bridging for IV to oral step-down.
Verify and authorize
Eligibility confirmed, prior authorization handled for high-cost antimicrobials, and the medical-necessity bridge for IV therapy reviewed against payer policy before the infusion is scheduled.
Document level of care and infusion times
Hospital E/M level selected from medical decision making, infusion start and stop times captured to the minute, and critical care minutes documented cumulatively for sepsis and severe presentations.
Code E/M, infusion, and drug by rule
E/M codes selected by payer, the 96365 and 96366 ladder applied by documented time, the correct J-code for the drug, and sepsis coded to organism specificity with the POA indicator.
Submit with JZ or JW where applicable
Claims filed with drug waste reported under JZ for single-use vials or JW for discarded amounts, NDC and HCPCS units reconciled, and prior authorization attached for high-cost agents.
Post and reconcile units to the EOB
Payment posting against the EOB, infusion units reconciled to the documented time, drug units matched to the dose, and the patient portion billed clearly.
Appeal and prevent
Denial recovery with root-cause analysis, so an infusion downgrade, a medical-necessity denial, or a missing waste modifier is appealed and prevented on the next cycle.
ProvidaRCM vs Generic Billing Companies
Infectious disease is not hospital medicine with a J-code added. The difference shows up in infusion time documentation, the 96365 and 96366 ladder, drug waste reporting, and sepsis coded to specificity.
ProvidaRCM
- Infusion time documented to the minute on every 96365 line
- 96365 and 96366 ladder applied, so first hour and each additional are captured
- Drug waste reported with JZ for single-use vials or JW for discards
- Sepsis coded to organism specificity with POA at admission
- OPAT supervised and documented, supervising physician and care plan on file
- Consult codes used correctly per payer, 99221 to 99223 for Medicare
- IV to oral step-down medical necessity documented and bridged in the record
- Cross-specialty coordination with nephrology, pulmonology, and hospital medicine
Generic Billing
- Infusion time rounded or missing on the 96365 line
- Additional infusion hours left unbilled beyond the first
- Drug waste written off silently, no JZ or JW reported
- Sepsis billed as A41.9 unspecified, POA indicator missing
- OPAT supervision undocumented, claim denies on submission
- 99244 to 99246 billed to Medicare and routinely denied
- IV therapy denied for lack of oral step-down medical necessity
- Infectious disease handled in a silo, no cross-specialty view
Is Your ID Practice Leaving Infusion Revenue Unbilled?
If any of these are true, your current billing is quietly costing you across infusion administration, drug waste, sepsis specificity, and OPAT supervision. A free audit will show exactly how much.
Infectious Disease Billing Questions, Answered
ID billing questions fall into three areas, diagnosis and consults, infusion and OPAT, and coverage and authorization. Each column below is an independent accordion stack, so find the theme that matches your question and open the answer that fits.
Diagnosis and Consults
No. Medicare does not pay consult codes. For a Medicare inpatient encounter, use 99221 to 99223 initial hospital care, selected by medical decision making, and for subsequent days use 99231 to 99233. Reserve 99244 to 99246 for non-Medicare payers that still cover outpatient consult codes, and confirm the payer policy before submission.
Sepsis is coded to the documented organism wherever one is identified. A41.01 is sepsis due to Staphylococcus aureus, A41.02 is MRSA sepsis, A41.51 is E. coli sepsis, and A41.4 is anaerobic sepsis. A41.9 unspecified sepsis is used only when no organism is documented. Severe sepsis with organ dysfunction uses R65.20, and severe sepsis with septic shock uses R65.21.
The present-on-admission indicator must be assigned at admission, not after discharge, and must reflect whether the sepsis was present on admission, hospital-acquired, or undetermined. A POA of Y means present at admission, N means not present and hospital-acquired, and U means undetermined. The POA indicator drives hospital-acquired condition tracking and affects reimbursement, so it is captured from the admission documentation, supported by the organism and severity codes.
Infusion and OPAT
96365 is the first hour of a therapeutic IV infusion and requires documented infusion time greater than 1 hour. The record must show the start time, the stop time, the drug given, the dose, and the route. Each additional hour beyond the first is reported with 96366. If the infusion time is 1 hour or less, the correct code is 96372 IV push, not 96365. The J-code for the drug is reported on the same line as the administration code.
96372 IV push is reported when the infusion is 15 minutes or less, or when the documented time does not meet the greater than 1 hour threshold for 96365. It is the correct downgrade when 96365 time is not met. We document the drug, the dose, and the push time, and we select 96372 rather than billing 96365 and watching it downgrade on the EOB.
Wasted drug from a single-use vial is reported with the JZ modifier to indicate no discarded amount, or with the JW modifier to report the actual discarded amount, depending on payer policy. The wasted units must match the documented dose and the vial size, and the NDC and HCPCS units must reconcile. We report waste on every eligible line so the discarded portion is reimbursed rather than written off.
Outpatient parenteral antimicrobial therapy requires a documented supervising physician, a care plan on file, and the home infusion services coded where the patient is managed at home. The supervision is documented in the record so the OPAT claim is supported, and the home infusion services are coded to the current CPT. Verify the current code status, since home infusion codes have been revised in recent CPT cycles.
Coverage and Authorization
IV antimicrobial therapy is medically necessary when the patient cannot tolerate or absorb oral therapy, when the severity of the infection requires IV treatment, when an oral equivalent does not exist for the organism, or when oral therapy has failed. The record must document the reason IV therapy is required, and the bridge to an oral step-down is captured when the patient meets conversion criteria. Without the medical-necessity documentation, the IV claim denies in favor of an oral equivalent.
Often yes. High-cost antimicrobials such as daptomycin, ceftazidime, and certain antivirals frequently require prior authorization, and the infusion denies when the authorization is not on file. We run prior authorization for high-cost agents before the infusion is scheduled, document the medical necessity, keep the authorization on file, and attach it to the claim so the drug line is paid rather than denied for a missing authorization.
Home IV therapy supervision and home infusion services are reported with the current CPT home infusion codes, such as 99605 and 99606 for home infusion services, with the supervising physician documented and the care plan on file. Older home IV supervision codes, including 99601 and 99602, have been revised or deleted in recent CPT cycles, so verify the current code status against the published CPT before billing home OPAT.
Capture Every Infusion Minute and Every Organism Code
Infectious disease revenue lives in documented infusion time, the correct J-code and waste modifier, sepsis coded to the organism with the POA indicator, and OPAT supervision on file. We run the cycle so every line pays what it should.
Free ID Billing Audit
We review your infusion time documentation, the 96365 and 96366 ladder, drug waste reporting, sepsis specificity, and OPAT supervision, and show exactly where revenue is leaking.
Talk to an ID Coder
A coder who knows the infusion time ladder, the JZ and JW waste modifiers, the sepsis ICD-10 specificity rules, and OPAT supervision reviews your workflow with you.
Revenue Cycle Live
We take over eligibility, prior authorization, infusion coding, drug waste reporting, claims, and denial recovery, so your ID revenue cycle runs end to end with no leakage.